BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 32809067)

  • 1. Imaging of Fontan-associated liver disease.
    Dillman JR; Trout AT; Alsaied T; Gupta A; Lubert AM
    Pediatr Radiol; 2020 Oct; 50(11):1528-1541. PubMed ID: 32809067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associated Factors of Liver Disease After Fontan Operation in Relation to Ultrasound Liver Elastography.
    Sethasathien S; Silvilairat S; Sittiwangkul R; Makonkawkeyoon K; Pongprot Y
    Pediatr Cardiol; 2020 Dec; 41(8):1639-1644. PubMed ID: 32740670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing hepatic impairment in Fontan-associated liver disease using the HepQuant SHUNT test.
    Lemmer A; VanWagner L; Gasanova Z; Helmke S; Everson GT; Ganger D
    Congenit Heart Dis; 2019 Nov; 14(6):978-986. PubMed ID: 31369200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congestive hepatopathy after Fontan operation and related factors assessed by transient elastography.
    Yoo BW; Choi JY; Eun LY; Park HK; Park YH; Kim SU
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1498-505. PubMed ID: 24823284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of Magnetic Resonance Elastography to Fontan Failure and Portal Hypertension.
    Alsaied T; Possner M; Lubert AM; Trout AT; Szugye C; Palermo JJ; Lorts A; Goldstein BH; Veldtman GR; Anwar N; Dillman JR
    Am J Cardiol; 2019 Nov; 124(9):1454-1459. PubMed ID: 31474329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fontan-Associated Liver Disease: Proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC.
    Daniels CJ; Bradley EA; Landzberg MJ; Aboulhosn J; Beekman RH; Book W; Gurvitz M; John A; John B; Marelli A; Marino BS; Minich LL; Poterucha JJ; Rand EB; Veldtman GR
    J Am Coll Cardiol; 2017 Dec; 70(25):3173-3194. PubMed ID: 29268929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fontan-Associated Liver Disease: Evidence for Early Surveillance of Liver Health in Pediatric Fontan Patients.
    Rathgeber SL; Harris KC
    Can J Cardiol; 2019 Feb; 35(2):217-220. PubMed ID: 30760429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of Fontan Associated Liver Disease in Childhood and Adolescence.
    Hansen JH; Khodami JK; Moritz JD; Rinne K; Voges I; Scheewe J; Kramer HH; Uebing A
    Semin Thorac Cardiovasc Surg; 2022; 34(2):642-650. PubMed ID: 33979666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fontan-associated liver disease: Diagnosis, surveillance, and management.
    de Lange C; Möller T; Hebelka H
    Front Pediatr; 2023; 11():1100514. PubMed ID: 36937979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous outcomes of liver disease after heart transplantation for a failed Fontan procedure.
    Ybarra AM; Khanna G; Turmelle YP; Stoll J; Castleberry CD; Scheel J; Ballweg JA; Ameduri R; Kimberling M; Makil E; Birnbaum BF; Exil V; Canter CE; Simpson KE
    Pediatr Transplant; 2021 Dec; 25(8):e14094. PubMed ID: 34296503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fontan-associated liver disease and hepatocellular carcinoma in adults.
    Kogiso T; Tokushige K
    Sci Rep; 2020 Dec; 10(1):21742. PubMed ID: 33303924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fontan-associated liver disease: Implications for heart transplantation.
    Greenway SC; Crossland DS; Hudson M; Martin SR; Myers RP; Prieur T; Hasan A; Kirk R
    J Heart Lung Transplant; 2016 Jan; 35(1):26-33. PubMed ID: 26586487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver Disease.
    Kim MH; Nguyen A; Lo M; Kumar SR; Bucuvalas J; Glynn EF; Hoffman MA; Fischer R; Emamaullee J
    Transplantation; 2021 Jan; 105(1):18-22. PubMed ID: 32639398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal liver lesions following Fontan palliation of single ventricle physiology: A radiology-pathology case series.
    Engelhardt EM; Trout AT; Sheridan RM; Veldtman GR; Dillman JR
    Congenit Heart Dis; 2019 May; 14(3):380-388. PubMed ID: 30569564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Fontan-associated Liver Disease and Ethnic Disparities in Long-term Survivors of the Fontan Procedure: A Population-based Study.
    Emamaullee J; Martin S; Goldbeck C; Rocque B; Barbetta A; Kohli R; Starnes V
    Ann Surg; 2022 Sep; 276(3):482-490. PubMed ID: 35766375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Mid-Term Liver Disease After the Fontan Procedure.
    Oka N; Miyamoto T; Tomoyasu T; Hayashi H; Miyaji K
    Int Heart J; 2020 Sep; 61(5):979-983. PubMed ID: 32921662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fontan-associated liver disease: Spectrum of US findings.
    Bae JM; Jeon TY; Kim JS; Kim S; Hwang SM; Yoo SY; Kim JH
    Eur J Radiol; 2016 Apr; 85(4):850-6. PubMed ID: 26971434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive assessment of liver abnormalities in pediatric Fontan patients.
    De Bruyne R; Vandekerckhove K; Van Overschelde H; Hendricx F; Vande Walle C; De Groote K; Panzer J; De Wolf D; Van Biervliet S; Bové T; François K
    Eur J Pediatr; 2022 Jan; 181(1):159-169. PubMed ID: 34231051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic stiffness in the bidirectional cavopulmonary circulation: The Liver Adult-Pediatric-Congenital-Heart-Disease Dysfunction Study group.
    Kutty SS; Zhang M; Danford DA; Hasan R; Duncan KF; Kugler JD; Quiros-Tejeira RE; Kutty S
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):678-684. PubMed ID: 26515874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Fontan operation on liver stiffness in children with single ventricle physiology.
    DiPaola FW; Schumacher KR; Goldberg CS; Friedland-Little J; Parameswaran A; Dillman JR
    Eur Radiol; 2017 Jun; 27(6):2434-2442. PubMed ID: 27752831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.